BBR Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,000
| Closed | -$390K | – | 263 |
|
|
2024
Q1 | $390K | Hold |
26,000
| – | – | 0.03% | 162 |
|
|
2023
Q4 | $390K | Hold |
26,000
| – | – | 0.04% | 120 |
|
|
2023
Q3 | $364K | Hold |
26,000
| – | – | 0.04% | 130 |
|
|
2023
Q2 | $269K | Hold |
26,000
| – | – | 0.03% | 132 |
|
|
2023
Q1 | $240K | Hold |
26,000
| – | – | 0.03% | 139 |
|
|
2022
Q4 | $231K | Hold |
26,000
| – | – | 0.03% | 155 |
|
|
2022
Q3 | $216K | Hold |
26,000
| – | – | 0.03% | 151 |
|
|
2022
Q2 | $213K | Sell |
26,000
-17,000
| -40% | -$139K | 0.02% | 196 |
|
|
2022
Q1 | $375K | Buy |
+43,000
| New | +$375K | 0.04% | 161 |
|